BackTC BioPharm (Holdings) plc - Warrants (08/02/2027) Overview
TC BioPharm (Holdings) plc - Warrants (08/02/2027)

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Return on Equity

Valuation check: TCBPW's ROE is -794.56%, below the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

-794.56%

Return on Equity

-794.56%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) (TCBPW) FAQ

The latest ROE for TCBPW is -794.56%. That is below the sector sector average of -5.87%. Investors often review this figure alongside TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, TCBPW currently prints -794.56% for ROE, while the sector average sits near -5.87%. That is roughly 13439.3% below the sector mean. Large gaps often invite a closer look at TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s growth, margins, and balance sheet.

Return on Equity shows how effectively TC BioPharm (Holdings) plc - Warrants (08/02/2027) converts resources into returns. At -794.56%, TCBPW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TCBPW's ROE (-794.56%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.